What Can You Expect at the 8th Exosome-Based Therapeutics Summit
Focusing on scale-up strategies, clinical data sharing, analytical development, regulatory compliance, clinical trial design, safety and efficacy insights, and investment challenges, the 8th Exosome-Based Therapeutics Summit is your one-stop hub for all things exosome and extra-cellular vesicle therapeutic development. Designed to address the industry’s most pressing hurdles, it brings together the insights and solutions needed to accelerate progress from early research through to commercialization.
Join leading innovators including Rion, Capricor Therapeutics, and Aegle Therapeutics as they share critical updates from their clinical and pipeline development journeys. By uniting 60+ Directors, VPs, Heads, Scientists, and C-level executives across clinical development, CMC, medical, and analytical functions, this summit offers a uniquely focused environment to connect, collaborate, and drive the field forward.
As the only annual event dedicated exclusively to exosome-based therapeutics, this summit is your essential touchpoint to stay at the forefront of innovation, collaboration, and clinical progress.
Unmissable Event Highlights
Hone the clinical applications of Rion’s platelet-derived exosome therapeutic to promote tissue repair and understand the future applications of exosome-based technologies
Gain key phase 3 clinical updates from Capricor Therapeutics’ Deramiocel and its potential in improved targeting mechanism and for anti-fibrosis and anti-inflammatory conditions
Identify regulatory pathways and understand the regulatory perspective to harmonize regulatory considerations and confidently move your therapeutic through the clinic with the NIH
Apply streamlined manufacturing considerations for improved batch to batch consistency and reduces costs with NurExone
Proactively develop potency assays to reflect proposed mechanism of action to better understand your therapeutic’s efficacy with Versatope Therapeutics
Attending Companies Include